Evidence-based therapy of androgenetic alopecia

ISSN： 2195-2175

Source： PHARMAKON, Vol.2, Iss.3, 2014-05, pp. : 183-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dutasteride in Androgenetic Alopecia: An Update

Current Clinical Pharmacology, Vol. 12, Iss. 1, 2017-06 ,pp. : 31-35

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence-Based Therapy for Cutaneous Sarcoidosis

By Doherty Christy B. Rosen Ted

Drugs, Vol. 68, Iss. 10, 2008-01 ,pp. : 1361-1383

Adis International

Access to resources Recommend Favorite

New investigational drugs for androgenetic alopecia

By Valente Duarte de Sousa Isabel Cristina Tosti Antonella

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 5, 2013-05 ,pp. : 573-589

Informa Healthcare

Access to resources Recommend Favorite

Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device–Controlled Multicenter Trial

By Kim Hyojin Choi Jee Woong Kim Jun Young Shin Jung Won Lee Seok-jong Huh Chang-Hun

Dermatologic Surgery, Vol. 39, Iss. 8, 2013-08 ,pp. : 1177-1183

Elsevier

Access to resources Recommend Favorite

Mortality reduced by evidence-based therapy use in STEMI

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 628, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite